---
title: "Precigen returns to profit in Q2 FY26; revenue rises to $54.98 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294869693.md"
description: "Precigen reported a return to profitability in Q2 FY26, posting net income of $20.07 million on revenue of $54.98 million, compared to a net loss of $26.64 million in the prior period. Operating income reached $22.64 million. The surge in product revenue to $53.26 million was driven by Papzimeos commercial sales following its FDA approval in August 2025. SG&A expenses rose 37.9% to $22.25 million due to commercialization activities."
datetime: "2026-08-04T20:42:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294869693.md)
  - [en](https://longbridge.com/en/news/294869693.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294869693.md)
generator: "portal-rs"
---

# Precigen returns to profit in Q2 FY26; revenue rises to $54.98 million

-   Precigen swung to net income of $20.07 million on revenue of $54.98 million in Q2 2026, from a net loss of $26.64 million on revenue of $856,000. \* Operating income was $22.64 million, versus an operating loss of $31.76 million. \* Product revenue rose to $53.26 million, reflecting Papzimeos commercial sales following FDA approval in August 2025. \* SG&A expense increased 37.9% to $22.25 million, driven by Papzimeos commercialization activities. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precigen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001356090-26-000030), on August 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PGEN.US](https://longbridge.com/en/quote/PGEN.US.md)

## Related News & Research

- [Precigen COO Rutul R. Shah sells 32,739 shares for $224,584.54](https://longbridge.com/en/news/295278251.md)
- [Precigen CFO Harry Thomasian Jr disposes of 100,000 shares worth $606,000](https://longbridge.com/en/news/294552595.md)
- [Precigen (PGEN) Projected to Release Earnings on Tuesday](https://longbridge.com/en/news/294091832.md)
- [Precigen CEO Helen Sabzevari disposes of 346,836 common shares worth $2,042,858.04](https://longbridge.com/en/news/291467254.md)
- [16:01 ETPrecigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth](https://longbridge.com/en/news/294862584.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**